Layoffs will be hitting 25% of employees across the Showtime, MTV Entertainment Studios and Paramount Media Networks groups in the U.S. Tuesday, following months of internal deliberations about ...
Amgen had sought to collect millions in damages from Sanofi because the pharmaceutical company makes a rival drug called ...
In such cases, one remedy is selling off assets to another party. But Amgen and Horizon have little product overlap and that’s not the argument the regulator is making now. Instead, the FTC says ...
While investors are accustomed to regulators under U.S. President Joe Biden citing potential harm to consumers in objecting ...
Fintech group Zepz, which owns money transfer brands WorldRemit and Sendwave, is laying off 420 employees, the company told CNBC exclusively. Zepz has a total head count of around 1,600 ...
The FTC filed a lawsuit in federal court to block the transaction, saying it would enable Amgen to use rebates on its existing blockbuster drugs to pressure insurance companies and pharmacy ...
We’ll send you a myFT Daily Digest email rounding up the latest Amgen Inc news every morning. US regulators have warned that “rampant consolidation” in the pharmaceuticals industry is ...
An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/ May 15 (Reuters) - The U.S. Federal Trade Commission is expected to ...
In a suit filed in federal court, the Federal Trade Commission (FTC) said the deal would enable Amgen to entrench the monopoly positions of Horizon medications to treat thyroid eye disease and ...
The euphoria was based on the premise that pharma companies would keep paying massive premiums for biotech companies because their own blockbuster drugs were going off patent.
May 16 (UPI) --The Federal Trade Commission said on Tuesday it will try to block an effort by biopharmaceutical leader Amgen Inc. from purchasing Horizon Therapeutics for $28.3 billion ...
The Federal Trade Commission sued to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. The FTC argued that the proposed deal would stifle drug competition in the pharmaceutical ...
